Explore our comprehensive collection of articles and resources about children's health, development, and well-being.
This article introduces Lymphoblastic lymphoma: T/B-cell origin, common pediatric NHL. Chemotherapy main treatment, 75-90% 5-year survival. Similar to ALL but <25% marrow involvement.
This article introduces Lymphoblastic lymphoma: T/B-cell origin, common pediatric NHL. Chemotherapy main treatment, 75-90% 5-year survival. Similar to ALL but <25% marrow involvement.
Lymphoblastic lymphoma